Biennial CEM in Women With a Personal History of Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer
Breast Neoplasms
Breast Cancer Female
Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 30 – 79
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 1,500 (estimated)
- Sponsor
- Wendie Berg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Asymptomatic women, ages 30-79, with a personal history of breast cancer who are at least one year out from any breast cancer surgery and/or treatment and are scheduled to have a routine annual mammogram with tomosynthesis (DBT).
Exclusion Criteria:
* Women with a history of…
Contacts